Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:bortezomib (250:1 mol/mol) |
PharmacoGx | tanespimycin:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTDSP2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
mRNA | CLIP1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
mRNA | CCL25 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | YWHAG | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | TNS1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
mRNA | NOV | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | CTF1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | FLVCR1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
mRNA | MRM3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | OR2A25 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |